OGT's chromosomal microarrays are a backbone of genomics laboratories and are regularly used in oncology research. Often the focus is the robust detection of oligonucleotide components, i.e., copy number changes, including exon-level.
In this presentation, Dr. Stephen Moore, Associate Professor of Molecular and Medical Genetics at Oregon Health and Science University and Director of the Clinical Cytogenetics and Clinical Molecular Diagnostics labs of the OHSU Knight Diagnostics Labs, will share his experience utilising OGT's CytoSure® chromosomal microarrays in various tumour types. Specifically, he will highlight the different applications of the single nucleotide polymorphism (SNP) track beyond oligonucleotides confirmation.
Dr. Stephen Moore, MBA, MS, PhD, FACMG
View Dr. Stephen Moore's profile on LinkedIn
This presentation is intended for educational purposes only and does not replace independent professional judgment. Statements of fact and opinions expressed are those of the presenters individually and, unless expressly stated to the contrary, are not the opinion or position of the Oxford Gene Technology Group (OGT). OGT does not endorse or approve, and assumes no responsibility for, the content, accuracy or completeness of the information presented.
CytoSure®: For research use only; not for use in diagnostic procedures.